OUR EXPERTISE

We’re a Bench-to-Market Life Science Provider

HEMEX is committed to changing the future of healthcare by guiding the most promising European start-ups through each and every step to bring innovative pharmaceuticals, medical devices and in vitro diagnostics to the market. Headquartered close to the thriving Basel global Life Sciences hub, the goal at HEMEX is to ensure start-ups have access to a wide range of tailored products, practical solutions and fundraising support, either in-house or via our network of pre-qualified experts, laboratories, CMOs, warehouses, logistic partners and affiliates. This empowers the next generation of transformative discoveries to grow into successful and sustainable businesses, and drive change in both human and animal healthcare.

Your journey from “green to gold”

Start-ups can enter the program at any stage.

We invest in selected life science start-ups that are part of the inQbator program, in cash and/or kind.

For scale up and close to market Start-ups; we are your trusted partner! We combine a series of professional services that are available to you in-house. Have a look at our pipeline of services.

learn more

DREAM

Your journey starts here. Ready to incorporate and not sure about the next steps? Come and see us, we offer an unbeatable one-stop-shop solution!

  • 1-5 founders
  • We give you some first advice for free
  • We help you apply for the Innosuisse coaching program
  • We discuss your financing options and show you how to get there
  • Our in-house notary and accountant will support you with incorporation and setting up your accounts
  • Our IP lawyers advise you on your patents and brands strategy

PLAN

Our lawyer and notary will help you draft all documents and guide you through the process of incorporation.

  • 2-5 first employees
  • You can join our incubator in Liestal (rent-a-desk or full-service virtual office)
  • We discuss with you the best way to get to market approval
  • We help you negotiate a license agreement with the university
  • We help you write a business and development plan
  • We help you find Seed financing
  • We help you with regulatory strategy for EMA and FDA

EXECUTE

Now is the time to put your plans into reality and continue with the product development. HEMEX will help you with all steps that are needed.

  • 5-10 employees
  • We help you with Series A financing
  • We set up your Quality Management System and perform (mock-)audits
  • We partner with you for non-dilutive grants
  • We support your product development with preclinical and clinical operations
  • We help you CE-mark your medical device or get positive CHMP/FDA opinion

SCALE

First sales! Profit is still a bit down the road, though. Scale up is needed, but growing pains are real. We’ll help you go international.

  • 10-50 employees
  • Obtain approval in your first market!
  • We help you with Series B financing
  • We help you develop an international (transfer) pricing strategy
  • We help you develop an approval and reimbursement strategy in the 7MM
  • We help you setting up licensing or co-marketing deals

PROFIT

Your business is sustainable now. Your “baby” has become an adolescent and it’s time to start thinking of letting go!

  • 50-200 employees
  • We help you complementing the founder team with internationally experienced C-level executives who can guide the company through the next stage
  • We help you with market access and insight services in order to boost sales
  • We help you find strategic partners and investors with merger and acquisition capabilities

EXIT

It’s time to reap the fruits of your hard work! We help you with the different options to cash in on your investment.

  • >200 employees
  • We help you implementing your exit strategies
  • Further financing via a co-development or co-marketing partner
  • Trade sale to a larger market player
  • Initial Public Offering

What our start-ups say

Hemex provides Scailyte a range of services, from administrative to highly specialized regulatory and clinical development support. Working at Hemex incubator, whenever we have a question, we can immediately address it. We’re happy to continue our journey with such a trusted partner.

From the start of Resistell, Hemex supports our company in the clinical operations and also back us with its investment arm. The understanding of startup needs, makes Hemex a unique partner in our journey to the market.

Hemex has been instrumental in Annaida Technologies’ progress. They were the first to recognize our potential and acted swiftly to support us in our development. We wouldn’t be where we are without their help.

Hemex supports us in marketing and sales, negotiating with industry partners and regulations. Their team is highly dedicated and delivers always on time and in high quality. Hemex is giving us the support we wished for.

Starting from our first meeting with Hemex, we have gained a lot of value from their life science experience and knowledge. We have received continuous support from Hemex that has brought Hi-D Imaging one step further towards our goals.

Dealing with HEMEX was a very pleasant experience. We felt very competently advised at all times and will be glad to use their services again in the future.

Hemex offers us great support on various levels thanks to their very good network of experts in different fields. We appreciate Hemex’s dedicated commitment in supporting our companies development.

Hemex provides Scailyte a range of services, from administrative to highly specialized regulatory and clinical development support. Working at Hemex incubator, whenever we have a question, we can immediately address it. We’re happy to continue our journey with such a trusted partner.

From the start of Resistell, Hemex supports our company in the clinical operations and also back us with its investment arm. The understanding of startup needs, makes Hemex a unique partner in our journey to the market.

Hemex has been instrumental in Annaida Technologies’ progress. They were the first to recognize our potential and acted swiftly to support us in our development. We wouldn’t be where we are without their help.

Hemex supports us in marketing and sales, negotiating with industry partners and regulations. Their team is highly dedicated and delivers always on time and in high quality. Hemex is giving us the support we wished for.

Starting from our first meeting with Hemex, we have gained a lot of value from their life science experience and knowledge. We have received continuous support from Hemex that brought Hi-D Imaging one step further towards our goals.

Dealing with HEMEX was a very pleasant experience. We felt very competently advised at all times and will be glad to use their services again in the future.

Hemex offers us great support on various levels thanks to their very good network of experts in different fields. We appreciate Hemex’s dedicated commitment in supporting our companies development.

AMT Medical develops a unique coronary bypass system. AMT’s technique enables the bypass surgery to be performed through small holes in the chest. This device has the potential to be the new standard, with lower costs for society, fewer complications, and a faster recovery for the patient.

Annaida Technologies logo

One in 10 couples experiences difficulties conceiving a child. Annaida’s patented NMR technology gives fertility doctors the ability to perform a fast, non-invasive and quantitative embryo screening, providing patients with an improved overall IVF experience.

Swiss startup Artidis Fundraising

The ARTIDISNet platform uses a nanomechanical sensor that captures the physical properties of tissue enabling the clinician to differentiate between benign and malignant tissue from biopsies in cancer patients in under three hours.

Swiss Startup Aspivix Logo Fundraising

ASPIVIX SA is a medical technology company specializing in Women’s Health, which has developed a flagship product called CAREVIX™. This technology is  proprietary vacuum & suction-based. It is used to reduce pain, eliminate bleeding, and tissue tear during gynecological procedures requiring uterus access.

BioReperia logo

BioReperia, based in Sweden and Switzerland, offers a highly precise, humanized zebrafish model to the pharmaceutical industry, to evaluate the safety and efficacy of oncology drug candidates in vivo, getting results as early as within a week.

haako breathe asthma app logo

Haako’s holistic asthma management solution Breathe helps parents of children with asthma. Allowing parents to track and better understand their child’s condition, they can make informed care decisions that achieve better patient outcome for children and less stress to parents.

Swiss Startup Emovo Logo Fundraising

Emovo Care SA has developed the world’s first portable hand orthosis to support care-at-home after a stroke, the Emovo Hand. This product provides a natural sensation of moving the hand to hemiparetic stroke patients to practice functional, comfortable, and intensive exercises directly at home. Emovo’s connected solution will enable to motivate and measure patients’ progress to maximize the outcome of care.

ender provides rapid and reliable testing kits for acute COVID–19 capable of diagnosing multiple samples at once and within just 30 minutes. These tests can be used in hospitals as well as right on-site.

 

Swiss startup GeneLook Fundraising

GeneLook allows patients suffering from rare diseases to access their DNA profile using their smartphone, using it for personalized healthcare and health alerts. In exchange, GeneLook’s business model will also give pharmaceutical companies access to this data to develop new therapies.

GeoHealthApp logo

geoHealthApp GmbH developed an App that has the potential to stop the spread of COVID19. An interactive map shows areas with high infection rates that can be evaded by the user. Based on anonymous smartphone location data and AI, users learn if they have been in contact with infected people during the last 14 days. The Beta Version has been launched in Germany, Switzerland, Austria, UK and USA.

HexagonFab’s team has developed a new generation of biosensors for rapid and highly sensitive analysis of biomolecules like antibodies, proteins, and small molecules. This award-winning technology, based on graphene nanomaterial, allows pharmaceutical researchers and production staff to monitor biomolecule quality directly at the production line, which offers a $1B market opportunity.

 

Swiss Startup Inura Medical Logo Fundraising

Inura Medical developed a urethral suppository with an approved pharmaceutical agent to help patients  who are suffering from two highly prevalent and disabling health disorders: overactive bladder (OAB) and nocturia.

Hi-D Imaging AG aims to revolutionize the cardiovascular sector by making personalized heart valve replacement therapy a reality. The world’s first AI-based pre-operational planning platform that assesses different heart valves for the patient‘s specific anatomy before the surgery. This technology increases the life quality of the patient and the success rate of the surgery.

Juvabis AG is a spin-off from the University of Zürich and ETH-Zürich, focusing on antimicrobial therapeutic drugs. Juvabis’ most advanced program is apramycin for infusion, a “best-in-class” antibiotic. Apramycin for infusion represents the most successful program within the pan-European ENABLE pipeline of the European Innovative Medicines Initiative.

 

LiVET develops and produces rapid molecular point-of-care diagnostic tests for the veterinary market. Based on LiVET’s proprietary platform technology, veterinarians can diagnose infectious diseases and parasites directly on-site within just 30 minutes. The test kits run on commercially available devices that enables the user to test up to 16 samples at once. This allows for immediate and specific treatment. The first test panel for respiratory diseases in horses includes Strangles, EHV 1+4 and Influenza and will be available in 2020.

Swiss Startup MOMM Diagnostics Logo Fundraising

MOMM Diagnostic’s patented technology is used to early detect a biomarker for pre-eclampsia (PE), a pregnancy disorder that can have devastating effects on the health of the mother and the unborn baby. Affecting 5-8% of all pregnancies, pre-eclampsia is a rapidly progressive and potentially deadly condition.

Opterion is improving the quality of life of Peritoneal Dialysis (PD) patients. They have developed a novel PD solution that is glucose-free and considerably decreases the metabolic and peritoneal challenge of diabetes patients.

 

PerioTrap Pharmaceuticals GmbH is developing a completely new concept for the treatment of periodontitis, one of the most widespread infectious diseases worldwide. PerioTrap aims to eradicate the root of the disease and to ultimately restore patient confidence.

 

PreComb Therapeutics AG is developing the first point-of-care solution for clinically relevant drug testing, influencing patient-derived 3D microtissues for drug development and precision medicine. With this technology the entire process of generating a high number of drug efficacy data can be fully automated, allowing the establishment of a clinical network and a scalable razor blade business model to finally guide therapeutic decisions.

Resistell logo

Resistell’s life-saving technology is based on the detection of movement caused by living bacterial cells and provides information on which antibiotic should be used to treat the patient, and the concentration at which it should be administered.

Swiss Startup Scailyte Logo Fundraising

Scailyte’s multi-disciplinary team is applying a data-driven approach to discover novel biomarkers and develop a new generation of precision diagnostics based on single-cell data and AI.

Sedimentum AG is a healthcare and tech startup developing the first contactless solution for fall and emergency detection in healthcare. This technological protection ensures the physical safety of people who are on their own without compromising privacy.

Swiss Startup Sleepiz Logo Fundraising

Sleepiz’s diagnostic device uses millimeter wave technology, sensor fusion, and machine learning to measure vital signs in a contactless and medical grade manner at home, completely changing the way disorders like sleep apnea are diagnosed.

STIMIT develops a non-invasive medical device that enables ICU patients to breath by stimulating diaphragm contractions, therefore creating natural breath instead of pumping air into the lungs with a machine. With this new therapy, the breathing muscle remains active and strong.

 

OUR PARTNERS

At Hemex we are dedicated to helping startups succeed. We partner with exceptionally motivated experts from business and life sciences, providing a combined knowledge platform with a considerable potential for new businesses.

MEET THE TEAM

Healthcare Management Experts

Each of our associates can rely on several years of specialized experience in the Life Science industry. In order to support your project from its inception to a future exit, we cover a broad area of expertise, ranging from clinical, quality and regulatory operations to financial, legal and business development.

We have 3 Innosuisse Coaches in our group: 1 Lead Coach and 2 Special Coaches (Intellectual Property and Fundraising & Investor Relations), so we can offer you all the support you need under one roof.

Rafiq
Medical / Ra

Vanessa
Legal

Franziska
commercial

Samidha
clinical

Pascal
CEO

Vanja
Clinical

Arthur
Veterinary

Laurène
Clinical

Yaozi
Communications

Juan
Digital Media

Werner
Board

Ivana
Digital Media

Paul
President

Dr. Philipp Marchand

Philipp
IP Consultant

Brigitte
IP Consultant

Dieter
Finance

Andreas
Business Coach

Beatrix
PR

Mohamed
Clinical

Kira
Clinical

Marilyn
Facility

Valentin
Sales Scale-up

Martin
coach

Stefan
Medical Innovation

Birgit
Market Insights

Kurt
Submissions

Virginia
Grants

João
Wearables expert

Pascal
QP

Lucie
Sales

Pascal
Sales

Marco
Sales

Serena
Office Manager

Clive
In vitro toxicologist

Head of Smart Cancer Co-Diagnostics 

(OncoGenomX)

 

 

Candidate Profile

Through your experience in the field you have the unique opportunity to bring
innovative decision support solutions to life, resolving the unmet medical
need of matching drugs with individual tumors as a prerequisite for optimal
treatment outcome in all cancer patients. You will have the meaningful and
rewarding role of supporting and guiding the therapeutic decision making of oncologists across cancer areas, and to lay the foundations for the use of our
support solutions across geographies.

If you are a pioneer, a creative problem solver with a passion for genomics,
digital health and artificial intelligence, if you are driven by an entrepreneurial
mindset, a leader by example and a team player, then you may be the right
candidate we are looking for.

Responsabilities

Your responsibilities will include but are not limited to:
1 – Building a commercialization-ready molecular diagnostics laboratory in
Switzerland that can serve as a laboratory model across other countries (EU,
US), including all activities required to achieve accreditation, certification and
reimbursement of our services, and in compliance with the effective
international and country-specific regulations and guidelines for diagnostic
laboratories, medical devices and SaaS.
2- Supporting the building of a laboratory franchise across Europe and North
America.
3- Guiding the team’s direction, maintaining overview of planning, progress,
quality and budget.
4- Supporting the development of SCCD solutions for other cancer entities
and advancing them to commercialization readiness state, in collaboration
with our bioinformatics team and experts in the respective cancer fields
beyond-breast cancer.
5- Driving your team to make OncoGenomX a preferred diagnostics service
provider thanks to agile execution and effective partnering with oncologists,
cancer care practitioners and hospitals.
As the Head of Smart Cancer Co-Diagnostics you will be part of the
OncoGenomX leadership team, reporting to the CEO, with an option of
earning stock options and becoming a partner and/or member of the
founders group.

OncoGenomX's offer

OncoGenomX is a Swiss venture founded in October 2019. Our mission is to
empower oncologists to choose precisely those drugs that will most
effectively help their patient to achieve durable disease control. This is made
possible by:
1- A gene expression assay to determine the biological properties,
pharmacological sensitivities and clinical behavior of individual tumors.
2- The use of artificial intelligence to determine which cancer drugs are
appropriate for every tumor and which will permanently prevent disease
progression or metastasis.
3- Provision of collective treatment results from comparable patients, who
have completed treatment informed by Smart Cancer Co-Diagnostics (SCCD).
4- A machine learning routine to continuously learn from previous treatment
decisions and therapy results.
The Head of Smart Cancer Co-Diagnostics is an exciting opportunity to set up
our Swiss Smart Cancer Co-Diagnostics Laboratory. (S)he will be responsible
for the organization and management of the laboratory, the formation of a
team and the extension of our support services to cancer types beyond
breast cancer.
At the heart of this opportunity lies the development and validation of gene
expression assays run on nCounter and Illumina instrumentation, their
validation, certification and advancement to commercialization readiness.

How to apply

Contact: Wolfgang Hackl, Managing Director OncoGenomX.

E-Mail: hacklwo@oncogenomx.com

Clinical Research Associate

[40-60%] [f/m/d]

 

 

Candidate Profile
  • Graduate qualification in nursing, life science, dentistry, medical sciences, pharmacy with at least 3-5 years clinical trial monitoring experience.
  • Good knowledge of ICH-GCP with some experience in biostatistics, managing clinical trial sites.
  • Working knowledge of Swiss/EU regulations for conducting clinical trials.
  • Good medical and scientific judgement.
  • Ability to evaluate, interpret and present scientific data.
  • Self-motivated, able to prioritize and plan effectively.
  • Attention to detail.
  • Able and willing to travel up to 50%.
  • Excellent knowledge of MS Office tools (Word, Excel, Outlook, …).
  • Excellent numerical, written and verbal communication skills.
  • Fluency in written and verbal English is a must. Good command on German and other languages is preferred.
  • Based in North-western Switzerland region.
Responsabilities

Your responsibilities will include but are not limited to:

  • Organise and manage multicentre clinical trials for investigational drugs/ medical devices/ diagnostic tests in order to make an accurate benefit/ risk analysis.
  • In-house and on-site clinical monitoring throughout the duration of the trial (site selection, site initiation/training visits, routine monitoring visits, close out visits).
  • Daily interactions with site staff (investigators, research coordinators, study nurses,…) in local language, as well as with internal and external stakeholders.
  • Evaluating the quality and integrity of site practices and escalating any quality issues appropriately.
  • Support and give guidance to the Clinical Operations team with writing clinical trial protocols, trial manuals, Case Report Forms (CRFs), Data Clarification Forms (DCFs), and other documentation.
  • Support logistics with supplying study centres with sufficient quantities of study drugs/equipment etc.
  • Training clinical study site staff on how to conduct the trials in accordance with GCP standards.
Our offer
  • Join a small team of multinational, multidisciplinary, highly motivated experts.
  • Modern, inclusive, pleasant working environment in a fast-growing, dynamic organization.
  • Ability to independently manage your role and responsibilities.
  • Opportunity to develop yourself and support start-ups developing highly innovative therapies.
  • Office-based employment in Liestal (Switzerland), 7min by foot from Liestal SBB train station.
How to apply

If you meet the described profile, we look forward to receiving your CV and cover letter in English, including supporting documents, by e-mail to serena.bologna@hemex.ch

We only accept direct applications of qualified candidates. Requests from headhunters and job agencies will not be answered.

LATEST NEWS

Our contact details

Office addresses

Hemex AG
Kasernenstrasse 30 | 4410 Liestal | Switzerland 

Hemex Germany GmbH
c/o Loeba Treuhand GmbH, Wallbrunnstr. 24 | 79539 Loerrach | Germany 

Hemex, LLC
The 5th Floor |  3801 Avalon Park East Blvd, Suite 200 | Orlando, FL 32828 | USA

Hemex APAC
c/o Launchpad APAC Pte. Ltd., 140 Robinson Road | #01 Crown At Robinson | Singapore 068907

E-Mail addresses

Hemex AG
info@hemex.ch
firstname.lastname@hemex.ch

Hemex Germany GmbH
info@hemex-germany.de
firstname.lastname@hemex-germany.de

Hemex, LLC
info@hemex-us.com
firstname.lastname@hemex-us.com

Telephone contact

Switzerland:

Mo-Fri 09:00-17:00 CET, our headquarters can be reached on (+41) 61-927-28-00.

Germany:

Mo-Fri 09:00-17:00 CET, our EU office can be reached on (+49) 1512-568-48-92.

USA:

Mo-Fri 7 a.m. to 6 p.m. EST, our headquarters can be reached on (+1) 689-219-8929

Emergencies:

24/7/365 emergency phone numbers: 

(+41) 79-833-73-30 (Switzerland) 

(+49) 1512-568-48-92 (Germany)

Accommodation

Hotel Engel: 2 min. on foot (ask for preferred HEMEX rate)

Hotel Bad Bubendorf: 10 min. by car

Send us an e-mail